ARDHEP may induce ferroptosis in ovarian tumor cells and prevent tumor cell growth by upregulating GPX4, increasing intracellular ROS and Fe(2+) buildup, and stimulating cellular oxidative damage (69). Here, GPX4 is linked to neoplasm.